No Data
No Data
Unusual Options Activity: APA, GNRC and Others Attract Market Bets, APA V/OI Ratio Reaches 868.8
Jefferies Maintains Intra-Cellular Therapies(ITCI.US) With Buy Rating, Maintains Target Price $105
Intra-Cellular Therapies(ITCI.US) Director Sells US$337.19K in Common Stock
Intra-Cellular Therapies Cut to Neutral From Buy by UBS
UBS Downgrades Intra-Cellular Therapies(ITCI.US) to Hold Rating, Raises Target Price to $83
RBC Capital Maintains Intra-Cellular Therapies(ITCI.US) With Buy Rating, Maintains Target Price $103